Fresenius SE & Co. KGaA (VIE:FRE)
Austria · Delayed Price · Currency is EUR 49.18
+0.87 (1.80%)
At close: Oct 23, 2025
Fresenius SE & Co. KGaA Company Description
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients.
It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products.
The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011.
Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Fresenius SE & Co. KGaA
| Country | Germany |
| Founded | 1912 |
| Industry | Miscellaneous Health And Allied Services, Not Elsewhere Classified |
| Employees | 176,486 |
| CEO | Michael Sen |
Contact Details
Address: Else-Kröner-Str. 1 Bad Homburg vor der Höhe, 61352 Germany | |
| Phone | 49 6172 6080 |
| Website | fresenius.com |
Stock Details
| Ticker Symbol | FRE |
| Exchange | Vienna Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Michael Sen | Chief Executive Officer |
| Sara Hennicken | Chief Financial Officer |
| Nick Stone | Head of Investor Relations |